Literature DB >> 12560384

Micropurification techniques in the analysis of amyloid proteins.

B Kaplan1, S Shtrasburg, M Pras.   

Abstract

This review describes the different microtechniques developed for the extraction and purification of amyloid proteins from small specimens of fresh and formalin fixed tissues. These procedures differ with respect to solvent type, extraction conditions, and protein purification strategy. The advantages and disadvantages of the different microtechniques are discussed by taking into consideration tissue type (fresh of fixed) and size, amyloid type, and its content in the tissue. The review demonstrates the applicability of these techniques for the immunochemical and chemical characterisation of amyloid in different clinical forms of amyloidosis and in experimental small animal models. The clinical value of the applied microtechniques and their importance in the study of the pathogenesis of amyloid related diseases are outlined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560384      PMCID: PMC1769876          DOI: 10.1136/jcp.56.2.86

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Determination of amyloid type by ELISA using milligram amounts of tissue.

Authors:  B Kaplan; G German; M Ravid; M Pras
Journal:  Clin Chim Acta       Date:  1994-09       Impact factor: 3.786

2.  Direct evidence for SAA deposition in tissues during murine amyloidogenesis.

Authors:  S Yakar; B Kaplan; A Livneh; B Martin; K Miura; Z Ali-Khan; S Shtrasburg; M Pras
Journal:  Scand J Immunol       Date:  1994-12       Impact factor: 3.487

3.  Application of formalin fixation to the purification of amyloid proteins.

Authors:  R Layfield; K Bailey; R Dineen; P Mehrotra; J Lowe; R Allibone; R J Mayer; M Landon
Journal:  Anal Biochem       Date:  1997-11-01       Impact factor: 3.365

4.  Extraction and protein sequencing of immunoglobulin light chain from formalin-fixed cerebrovascular amyloid deposits.

Authors:  R Layfield; K Bailey; J Lowe; R Allibone; R J Mayer; M Landon
Journal:  J Pathol       Date:  1996-12       Impact factor: 7.996

5.  Detection of serum amyloid A-derived proteins in formalin-fixed paraffin-embedded tissues: reliability of the method and expansion of its spectrum.

Authors:  S Shtrasburg; A Livneh; M Pras; T Weinstein; R Gal
Journal:  Am J Clin Pathol       Date:  1997-09       Impact factor: 2.493

6.  Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain.

Authors:  L Eriksson; K Sletten; L Benson; P Westermark
Journal:  Scand J Immunol       Date:  1993-06       Impact factor: 3.487

7.  Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation.

Authors:  B Kaplan; R Vidal; A Kumar; J Ghiso; B Frangione; G Gallo
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

8.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.

Authors:  H Mori; K Takio; M Ogawara; D J Selkoe
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

9.  Separation of proteins by consecutive sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and reversed phase high performance liquid chromatography.

Authors:  B Kaplan; M Pras
Journal:  Biomed Chromatogr       Date:  1991-03       Impact factor: 1.902

10.  Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis.

Authors:  P Westermark; L Benson; J Juul; K Sletten
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

View more
  8 in total

Review 1.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

2.  Primary local orbital amyloidosis: biochemical identification of the immunoglobulin light chain kappaIII subtype in a small formalin fixed, paraffin wax embedded tissue sample.

Authors:  B Kaplan; B M Martin; H I Cohen; J Manaster; Y Kassif; U Rehany; A Livneh
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

3.  Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.

Authors:  Batia Kaplan; Brian M Martin; Olga Boykov; Rivka Gal; Mordechai Pras; Itzhak Shechtman; Milton Saute; Mordechai R Kramer
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

4.  Current treatment in cardiac amyloidosis.

Authors:  Ivana Kholová; Josef Kautzner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

5.  Protein Engineering Reveals Mechanisms of Functional Amyloid Formation in Pseudomonas aeruginosa Biofilms.

Authors:  Alissa Bleem; Gunna Christiansen; Daniel J Madsen; Hans Maric; Kristian Strømgaard; James D Bryers; Valerie Daggett; Rikke L Meyer; Daniel E Otzen
Journal:  J Mol Biol       Date:  2018-06-30       Impact factor: 5.469

Review 6.  Neurodegenerative Proteinopathies in the Proteoform Spectrum-Tools and Challenges.

Authors:  Aneeqa Noor; Saima Zafar; Inga Zerr
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

Review 7.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

8.  Dynamic Sumoylation of a Conserved Transcription Corepressor Prevents Persistent Inclusion Formation during Hyperosmotic Stress.

Authors:  Michelle L Oeser; Triana Amen; Cory M Nadel; Amanda I Bradley; Benjamin J Reed; Ramon D Jones; Janani Gopalan; Daniel Kaganovich; Richard G Gardner
Journal:  PLoS Genet       Date:  2016-01-22       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.